SleepActa is a private company (SRL) incorporated in 2017. Its mission is to develop and market novel ways to screen and analyse sleep/circadian patterns and disorders, and to suggest viable therapeutic pathways. sleepActa has developed a certified software for analysing sleep and waking (Electromedical Device certification type I, Italian Ministry of Health, BD/RDM number 1763747) marketed and register under the name Dormi. Its commercial network has steadily increase in the past two year reaching out to more than 100 pharmacies where the main target of the product are involved. sleepActa is a Spinoff of the University of Pisa and the founders have a strong research biomedical background, an important asset in the development of machine-learning based algorithms applied to biological signals recorded from wearable devices. A GDPR compliant in cloud platform makes the collection of data and the production of clinical reports userfriendly for the adoption of a diverse population of professionals. More than 50% of its current budget are invested in R&D.